Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo de Braud

Showing results (71-80 of 497) with videos related to

Pageof 50
Sort By:
Journal of the National Cancer Institute|March 17, 2005
Re: Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancerFilippo de Braud, Tommaso De Pas, Lorenzo Spaggiari, et al.
Oncology|May 29, 2013
Is a dexamethasone-sparing strategy capable of preventing acute and delayed emesis caused by combined doxorubicin and paclitaxel for breast cancer? Analysis of a phase II trialSilvia Damian, Luigi Celio, Elena De Benedictis, et al.
The Annals of Thoracic Surgery|January 17, 2004
Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?Francesco Leo, Piergiorgio Solli, Lorenzo Spaggiari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Prophylaxis for venous thromboembolism in cancer patients with a central vein catheter: new tones for an old songGiuseppe Curigliano, Marco Colleoni, Mario Mandalà, et al.
The Oncologist|March 7, 2015
In replyDario Baratti, Shigeki Kusamura, Claudia Maggi, et al.
Current Drug Targets|November 21, 2014
Inhibition of the VEGF/VEGFR pathway improves survival in advanced kidney cancer: a systematic review and meta-analysisRoberto Iacovelli, Cora N Sternberg, Camillo Porta, et al.
Journal of Cancer Research and Clinical Oncology|December 13, 2018
Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanomaAlice Indini, Lorenza Di Guardo, Carolina Cimminiello, et al.
Expert Review of Anticancer Therapy|December 15, 2015
Treatment of elderly patients with metastatic renal cell carcinomaElisa Zanardi, Paolo Grassi, Alessia Cavo, et al.
Frontiers in Oncology|January 10, 2019
MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature ReviewGiuseppe Lo Russo, Anna Tessari, Marina Capece, et al.
Tumori|December 12, 2013
Well-differentiated neuroendocrine tumor of tailgut cyst. A rare entity with controversial medical opportunitiesAngela Damato, Sara Pusceddu, Massimo Milione, et al.
Pageof 50

Showing results (71-80 of 497) with videos related to

Sort By:
Pageof 50
Journal of the National Cancer Institute|March 17, 2005
Re: Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancerFilippo de Braud, Tommaso De Pas, Lorenzo Spaggiari, et al.
Oncology|May 29, 2013
Is a dexamethasone-sparing strategy capable of preventing acute and delayed emesis caused by combined doxorubicin and paclitaxel for breast cancer? Analysis of a phase II trialSilvia Damian, Luigi Celio, Elena De Benedictis, et al.
The Annals of Thoracic Surgery|January 17, 2004
Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?Francesco Leo, Piergiorgio Solli, Lorenzo Spaggiari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Prophylaxis for venous thromboembolism in cancer patients with a central vein catheter: new tones for an old songGiuseppe Curigliano, Marco Colleoni, Mario Mandalà, et al.
The Oncologist|March 7, 2015
In replyDario Baratti, Shigeki Kusamura, Claudia Maggi, et al.
Current Drug Targets|November 21, 2014
Inhibition of the VEGF/VEGFR pathway improves survival in advanced kidney cancer: a systematic review and meta-analysisRoberto Iacovelli, Cora N Sternberg, Camillo Porta, et al.
Journal of Cancer Research and Clinical Oncology|December 13, 2018
Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanomaAlice Indini, Lorenza Di Guardo, Carolina Cimminiello, et al.
Expert Review of Anticancer Therapy|December 15, 2015
Treatment of elderly patients with metastatic renal cell carcinomaElisa Zanardi, Paolo Grassi, Alessia Cavo, et al.
Frontiers in Oncology|January 10, 2019
MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature ReviewGiuseppe Lo Russo, Anna Tessari, Marina Capece, et al.
Tumori|December 12, 2013
Well-differentiated neuroendocrine tumor of tailgut cyst. A rare entity with controversial medical opportunitiesAngela Damato, Sara Pusceddu, Massimo Milione, et al.
Pageof 50